Natural Compound Therapies
Total Trials
8
As Lead Sponsor
7
As Collaborator
1
Total Enrollment
1,007
NCT01167127
Oxycodone/Naloxone (OXN) Combination in Moderate to Severe Non-malignant Pain
Phase: Phase 3
Role: Lead Sponsor
Start: Jun 30, 2009
Completion: Apr 30, 2011
NCT01167699
NCT01376401
Bendamustine, Bortezomib (Velcade ®) and Prednisone (BVP) in Patients Newly Diagnosed Multiple Myeloma
Phase: Phase 2
Role: Collaborator
Start: Jul 31, 2011
Completion: Dec 31, 2015
NCT02519387
Efficacy and Safety of Buprenorphine Transdermal Patch in Non-cancer Pain of Moderate Intensity
Phase: Phase 4
Start: Jul 31, 2013
Completion: Jan 31, 2015
NCT02811315
Flutiform in Treatment of Patients With Asthma in Daily Clinical Practice.
Phase: N/A
Start: Jul 31, 2016
Completion: Dec 15, 2016
NCT03256903
Methoxyflurane vs Standard Analgesic Treatment for Trauma Pain in Spanish Emergency Units
Start: Jul 7, 2017
Completion: Jul 31, 2018
NCT03585374
Trauma Acute Pain Treatment With Methoxyflurane Vaporized (PENTHROX®): Efficacy and Safety Study (MEDITA)
Start: Feb 8, 2018
Completion: Feb 22, 2019
NCT04271839
Efficiency Control of Fluticasone/Formoterol K-haler (Medium Strength) vs ICS/LABA (High Strength) in Asthma Patients
Start: Jun 11, 2020
Completion: May 31, 2021
Loading map...